PTGX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protagonist Therapeutics Inc

Watchlist Manager

Watchlist

Price: 99.98 USD 0.8% Market Closed

Market Cap: $6.4B

	Protagonist Therapeutics Inc NASDAQ:PTGX	US
A	Aeluma Inc OTC:ALMU	US
	Davide Campari Milano NV MIL:CPR	IT
F	First Watch Restaurant Group Inc NASDAQ:FWRG	US
M	Myriad Genetics Inc LSE:0K3W	US
U	Unisys Corp SIX:UIS	US
	UPM-Kymmene Oyj OMXH:UPM	FI
	Guotai Junan Securities Co Ltd SSE:601211	CN
B	Boyd Gaming Corp DUS:BO5	US
S	Synaptics Inc SWB:SJN	US
C	Chongqing Water Group Co Ltd SSE:601158	CN

Profitability Summary

Protagonist Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-192%

Negative 3Y Average Operating Margin

-46%

Operating Margin is Increasing

-17 009% > -192%

Negative Net Margin

-155%

Negative 3Y Average Net Margin

-27%

Net Margin is Increasing

-16 301% > -155%

Negative Free Cash Flow Margin

-159%

Strong 3Y Average Free Cash Flow Margin

22%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-257%

ROIC is Increasing

-715% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.